Phreesia Inc(PHR)
USD --+0.00%
Reward62Moderate
Risk44Moderate
📊75%Data
Thin -1% profit margin · Revenue growing 46% YoY
PHR
+0.0 · +0.00%
USD · NYSE
Phreesia Inc | Healthcare
Growth Machine
Market Cap:743.34M
ℹ️
Reward Rating
62
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
44
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PHR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $28.05.

What is Phreesia Inc?

provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

PHR · Verdict

Solid reward · moderate risk

PHR stands out on growth and volatility, but watch the profitability signal.

Based on 88% data coverage

PHR · Verdict

What’s working & what to watch

Strengths 2

  • Growth78/100

    Rev +25.3% CAGR · earnings -20.9%

  • Volatility65/100

    Above average

Watchouts 1

  • Profitability44/100

    -14% net margin · -2% ROE

Model-based scoring. For information only — not financial advice.

What is Phreesia Inc?

provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 743.34M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (62)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap743.34M
P/E RatioN/A
Dividend YieldN/A
52 Week High32.76
52 Week Low11.31
Last AnnualJanuary
IPO Date7/18/2019
IncorporatedUSA
Shares Outstanding60M
No. of Employees2,082
IndustryHealth Information Services
ExchangeNYSE
Beta0.659
CurrencyUSD